PAGNINI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.618
EU - Europa 1.271
AS - Asia 291
AF - Africa 6
OC - Oceania 1
SA - Sud America 1
Totale 4.188
Nazione #
US - Stati Uniti d'America 2.610
PL - Polonia 405
IE - Irlanda 269
SE - Svezia 222
IT - Italia 191
HK - Hong Kong 112
CN - Cina 71
JO - Giordania 45
FI - Finlandia 44
IN - India 32
GB - Regno Unito 24
DE - Germania 20
RU - Federazione Russa 20
AT - Austria 18
CH - Svizzera 15
UA - Ucraina 15
ES - Italia 9
TR - Turchia 9
CA - Canada 8
VN - Vietnam 8
BE - Belgio 7
FR - Francia 5
IQ - Iraq 5
SC - Seychelles 5
SG - Singapore 5
NL - Olanda 4
HR - Croazia 2
AU - Australia 1
BH - Bahrain 1
BR - Brasile 1
CZ - Repubblica Ceca 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
MU - Mauritius 1
Totale 4.188
Città #
Fairfield 438
Warsaw 404
Dublin 264
Ashburn 256
Chandler 246
Woodbridge 186
Cambridge 180
Seattle 168
Houston 158
Wilmington 151
Lawrence 100
Altamura 95
Ann Arbor 83
Princeton 79
Hong Kong 62
Medford 52
Beijing 45
Buffalo 34
Boston 33
San Diego 32
New York 24
Pune 24
Shanghai 20
Boardman 18
Jacksonville 18
Vienna 18
Moscow 17
Bern 15
Florence 14
Norwalk 13
Falls Church 12
Kent 12
Milan 11
Hillsboro 10
Barcelona 9
Chennai 8
Dong Ket 8
Izmir 8
Brussels 6
Erbil 5
Frankfurt Am Main 5
Singapore 5
Cagliari 4
London 4
Menlo Park 4
Naples 4
Toronto 4
Trieste 4
Akron 3
Andover 3
Dearborn 3
Edmonton 3
Guangzhou 3
Kilburn 3
Philadelphia 3
Verona 3
Bollate 2
Central 2
Islington 2
Laurel 2
Los Angeles 2
Phoenix 2
Prato 2
Reggio Emilia 2
Washington 2
Wernigerode 2
Zagreb 2
Amsterdam 1
Ankara 1
Arezzo 1
Bari 1
Bremen 1
Cantagallo 1
Chicago 1
Fiesole 1
Gloucester 1
Granarolo 1
Groningen 1
Grossmuehlingen 1
Helsinki 1
Huntsville 1
Kagoya 1
Kish 1
Leawood 1
Leuven 1
Lisburn 1
Livorno 1
Lonate Pozzolo 1
Ludwigshafen am Rhein 1
Manama 1
Montréal 1
Nanjing 1
New Bedfont 1
Palo Alto 1
Pisa 1
Poggibonsi 1
Pontedera 1
Portland 1
Rotterdam 1
San Mateo 1
Totale 3.449
Nome #
biologic therapy in children with enthesitis-related arthritis the fist year after disease onset 195
The intestinal microbiota in enthesitis-related arthitis 189
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. 179
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. 161
Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis. 117
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 111
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 111
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 109
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. 105
Oral clonidine provocative test in the diagnosis of growth hormone deficiency in childhood: should we make the timing uniform? 100
Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response 95
Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options 92
Glucocorticoids in the management of systemic juvenile idiopathic arthritis. 92
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. 91
Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. 91
Sequential MR angiography in childhood primary angiitis of the CNS. 91
Macrophage activation syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki disease. 86
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis 85
Development and retrospective validation of the juvenile spondyloarthritis disease activity index. 81
Clinical features and outcome of Cogan syndrome. 80
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 79
Distal extremity pain as a presenting feature of Fabry's disease. 77
Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis 74
Utility of magnetic resonance imaging when following up sacroiliitis in enthesitis-related arthritis. 70
Treatment strategies for childhood noninfectious chronic uveitis: an update. 69
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 68
Distal limb pain as presenting feature of Fabry disease. 64
Switching from Reference to Biosimilars Does Not Reduce Efficacy and Safety in Juvenile Idiopathic Arthritis 63
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis. 60
Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis. 57
What do cytokine profiles tell us about subsets of juvenile idiopathic arthritis? 52
Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment 51
OBSIDIAn - real world evidence of Originator to BioSImilar Drug switch in juvenile idiopathic arthritis 51
Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms 50
AB1025 Chronic Recurrent Multifocal Osteomyelitis (CRMO): The Importance of an Accurate Differential Diagnosis 50
Diagnostic challenge of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome in pediatric age: A monocentric case series 49
Circulating levels of vaspin and omentin, two novel adipokines, in juvenile idiopathic arthritis 48
Cutaneous polyarteritis nodosa and common variable immunodeficiency: a previously unreported association. 46
The off-label use of anakinra in pediatric systemic autoinflammatory diseases 44
Cervical arthritis as early manifestation of enthesitis-related arthritis complicated by uveitis 44
The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity? 44
Anti-Drug Antibodies Are Associated with Diminished Drug Levels and Treatment Failure 43
Clinical and Therapeutic Features of 312 Patients with Macrophage Activation Syndrome Enrolled in a Multinational Survey 43
Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports 43
Cogan Syndrome: a rare but severe vasculitis in pediatric age 42
Kawasaki disease 2013: Clinical cases and new issues 38
 A Rare Case of Neonatal Antiphospholipid Syndrome 38
Ocular involvement in monogenic autoinflammatory disease: A systematic literature review 38
Oral clonidine provocative test in the diagnosis of growth hormone deficiency (GHD) in childhood: should we make the timing uniform? 37
BONE STATUS OF CHILDREN BORN FROM MOTHERS WITH AUTOIMMUNE DISEASES TREATED DURING PREGNANCY WITH LOW MOLECULAR WEIGHT HEPARIN AND/OR PREDNISONE 37
Increased percentages of tumor necrosisfactor-alpha+/interferon-gamma+ lymphocytes and calprotectin+/tumor necrosisfactor-alpha+ monocytes in patients with acute Kawasaki disease 35
Pathogenesis of Juvenile Idiopathic Arthritis: A Review of the Possible Role of Different Synovial Fluid T Lymphocyte Subsets 35
Biological drugs in paediatric COVID-19 infection: what patients, which drug, how much and how long 35
 Possible Correlation Between Congenital Heart Block and Autoimmune Hearing Loss 34
Final height in females and males with precocious puberty after GnRHa treatment 32
Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments 32
Successful treatment of adalimumab in a child with Vogt-Koyanagi-Harada: which is the best available systemic treatment? 30
Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation. 29
Pathogenesis of juvenile idiopathic arthritis: A review of the possible role of different synovial fluid T lymphocyte subsets 29
Behçet syndrome in children and adults: discovering similarities and differences by a comparative study 27
Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism. 25
STAT3-confusion-of-function: Beyond the loss and gain dualism 23
CD38high/HLA-DR+ CD8+ T cells as potential biomarker of hemophagocytic lymphohistiocytosis secondary to visceral Leishmania infection 23
Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis. 20
Usefulness of autoantibodies against inner ear antigens for the diagnosis 19
Increased percentages of tumor necrosis factor-alpha+/interferon-gamma+ T [corrected] lymphocytes and calprotectin+/tumor necrosis factor-alpha+ monocytes in patients with acute Kawasaki disease. 17
Thrombotic Events in MIS-C Patients: A Single Case Report and Literature Review 15
Totale 4.290
Categoria #
all - tutte 14.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019165 0 0 0 0 0 0 0 0 0 0 0 165
2019/2020846 85 46 29 64 99 93 100 99 93 65 61 12
2020/2021382 35 37 20 38 37 35 19 37 29 57 18 20
2021/2022518 4 79 69 34 8 12 15 45 17 17 68 150
2022/20231.238 111 276 58 83 72 214 167 59 127 11 31 29
2023/2024454 14 44 71 18 36 109 24 82 12 18 21 5
Totale 4.290